Search results
Brazil securities regulator CVM asks to more than double staff, raise fees
Reuters via Yahoo Finance· 3 weeks agoBRASILIA (Reuters) -Brazil's securities regulator (CVM) has asked the government to more than double...
10-Year Phase 3 Trial Shows CEL-SCI's Multikine immunotherapy Extends Lives In Head & Neck Cancer...
Benzinga via Yahoo Finance· 1 year agoCEL-SCI Corporation (NYSE: CVM) said that its 10-year Phase 3 trial showed that Multikine...
Brazilian securities watchdog launches new probes into Americanas accounting fiasco
Reuters via Yahoo Finance· 1 year agoBrazilian securities watchdog CVM said on Friday it has launched two new probes into retailer...
Crypto Exchange Bybit Barred From Brokering Securities in Brazil
CoinDesk via Yahoo Finance· 2 years agoInfoMoneyCoinDesk Brasil on Twitter. The Brazilian Securities and Exchange Commission (CVM) banned...
Brazil’s unlikely bid to become a global crypto hub
Fortune via Yahoo Finance· 12 months agoProof of State is the Wednesday edition of Fortune Crypto where Leo Schwartz delivers insider insights on policy and regulation. Daniel Walter Maeda...
Brazil watchdog offers plea deals to Americanas employees in fraud probe
Reuters via Yahoo Finance· 10 months agoThe president of Brazil's securities watchdog CVM on Tuesday urged employees from Americanas with...
Brazil’s Securities Regulator Allows Investment Funds to Invest in Crypto
CoinDesk via Yahoo Finance· 1 year agoInfoMoneyCoinDesk Brasil on Twitter. The Brazilian Securities and Exchange Commission (CVM) on...
Brazil’s Securities Regulator Probes Crypto Exchange Mercado Bitcoin on Token Issuance
CoinDesk via Yahoo Finance· 2 years agoInfoMoneyCoinDesk Brasil on Twitter. The Brazilian Securities and Exchange Commission (CVM)...
Crypto Exchange Bybit Halts Derivatives Trading in Brazil After Exchange Commission Ban
CoinDesk via Yahoo Finance· 2 years agoInfoMoneyCoinDesk Brasil on Twitter. Singapore-based cryptocurrency exchange Bybit will stop...
Why CEL-SCI Shares Are Shooting Higher Today
Benzinga via Yahoo Finance· 12 months agoCEL-SCI Corporation (NYSE: CVM) announced that the latest results from its pivotal Phase 3 study of Multikine, a presurgical cancer immunotherapy, were...